{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T23:55:12Z","timestamp":1703634912684},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T00:00:00Z","timestamp":1352332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00520-012-1636-z","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T03:26:31Z","timestamp":1352258791000},"page":"1131-1135","source":"Crossref","is-referenced-by-count":1,"title":["Which patients with advanced cancer and biliary obstruction benefit from biliary stenting most? An analysis of prognostic factors"],"prefix":"10.1007","volume":"21","author":[{"given":"H\u00fcseyin","family":"Abali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"O\u011fuzkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U\u011fur","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Ayberk","family":"Be\u015fen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Taner","family":"S\u00fcmb\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut","family":"Di\u015fel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sad\u0131k","family":"Muallao\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zg\u00fcr","family":"\u00d6zy\u0131lkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,8]]},"reference":[{"key":"1636_CR1","first-page":"385","volume":"53","author":"TA Stellato","year":"1987","unstructured":"Stellato TA, Zollinger RM Jr, Shuck JM (1987) Metastatic malignant biliary obstruction. Am Surg 53:385\u2013388","journal-title":"Am Surg"},{"key":"1636_CR2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1200\/JCO.1987.5.6.969","volume":"5","author":"JJ Lokich","year":"1987","unstructured":"Lokich JJ, Kane RA, Harrison DA, McDermott WV (1987) Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. J Clin Oncol 5:969\u2013981","journal-title":"J Clin Oncol"},{"key":"1636_CR3","unstructured":"Adler DG, Byrne KR (2011) Endoscopic stenting for malignant pancreaticobiliary obstruction. http:\/\/www.uptodate.com\/contents\/endoscopic-stenting-for-malignant-pancreaticobiliary-obstruction , accessed on 10.10.2011"},{"key":"1636_CR4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00330-007-0796-6","volume":"18","author":"OM Delden van","year":"2008","unstructured":"van Delden OM, Lam\u00e9ris JS (2008) Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol 18:448\u2013456","journal-title":"Eur Radiol"},{"key":"1636_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/02841859609177649","volume":"37","author":"S Men","year":"1996","unstructured":"Men S, Hekimoglu B, Kaderoglu H, Pinar A et al (1996) Palliation of malignant obstructive jaundice. Use of self-expandable metal stents. Acta Radiol 37:259\u2013266","journal-title":"Acta Radiol"},{"key":"1636_CR6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.giec.2011.04.004","volume":"21","author":"C Gerges","year":"2011","unstructured":"Gerges C, Schumacher B, Terheggen G, Neuhaus H (2011) Expandable metal stents for malignant hilar biliary obstruction. Gastrointest Endosc Clin N Am 21:481\u2013497","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"1636_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ctrv.2006.10.006","volume":"33","author":"AC Moss","year":"2007","unstructured":"Moss AC, Morris E, Leyden J, MacMathuna P (2007) Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 33:213\u2013221","journal-title":"Cancer Treat Rev"},{"key":"1636_CR8","unstructured":"International Agency For Research on Cancer. Globocan 2008. http:\/\/globocan.iarc.fr\/bar_sex_pop.asp?selection=221900&title=World&statistic=1&number=20&window=1&grid=1&info=1&color1=4&color1e=&color2=5&color2e=&submit=%A0Execute%A0 , accessed on 11.10.2011"},{"key":"1636_CR9","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.2010.28.0982","volume":"29","author":"NJ Robert","year":"2011","unstructured":"Robert NJ, Di\u00e9ras V, Glaspy J, JRIBBON-1 et al (2011) Randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer. J Clin Oncol 29:1252\u20131260","journal-title":"J Clin Oncol"},{"key":"1636_CR10","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M et al (2011) Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817\u20131825","journal-title":"N Engl J Med"},{"key":"1636_CR11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, ABC-02 Trial Investigators et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362:1273\u20131281","journal-title":"N Engl J Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1636-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1636-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1636-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:04:21Z","timestamp":1559095461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1636-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,8]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1636"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1636-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,8]]}}}